TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
- DOI
- 10.1016/j.omto.2017.09.001
- Published
- 2017-12
- Container
- Molecular Therapy - Oncolytics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omto.2017.09.001,
title = {TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma},
author = {Brian Hutzen and Chun-Yu Chen and Pin-Yi Wang and Les Sprague and Hayley M. Swain and Julia Love and Joe Conner and Louis Boon and Timothy P. Cripe},
year = {2017},
journal = {Molecular Therapy - Oncolytics},
doi = {10.1016/j.omto.2017.09.001},
url = {https://doi.org/10.1016/j.omto.2017.09.001}
}RIS
TY - JOUR TI - TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma AU - Brian Hutzen AU - Chun-Yu Chen AU - Pin-Yi Wang AU - Les Sprague AU - Hayley M. Swain AU - Julia Love AU - Joe Conner AU - Louis Boon AU - Timothy P. Cripe PY - 2017 JO - Molecular Therapy - Oncolytics DO - 10.1016/j.omto.2017.09.001 UR - https://doi.org/10.1016/j.omto.2017.09.001 ER -
APA
Hutzen, B., Chen, C., Wang, P., Sprague, L., Swain, H. M., Love, J., Conner, J., Boon, L., & Cripe, T. P. (2017). TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma. Molecular Therapy - Oncolytics. https://doi.org/10.1016/j.omto.2017.09.001
Source records
- crossref · retrieved 2026-09-27T11:01:18.317Z